(
A) Schematic representation of the construct for conditional targeting of the
Pcgf6 locus. The targeting construct contains an FRT (closed arrows)-flanked neomycin resistance gene (neo), and the second and the third exons (closed rectangles) of the mouse
Pcgf6 gene are flanked by two loxP sites (open triangles). (
B) Genomic PCR using the indicated primers demonstrating the kinetics of the excision of the loxP-flanked region in
Pcgf6fl/fl; Rosa26::CreERT2tg/+ ESCs after OHT treatment. (
C) Comparison of the PCGF6 ChIP-seq data in this study with those reported in a previous paper (
Yang et al., 2016). (
D) ChIP-qPCR data showing a strong binding of FLAG-tagged PCGF6 to representative PCGF6 targets (
Ddx4,
Tdrd1,
Spo11 and
Stag3) determined by ChIP-seq analysis shown in
Figure 1 and a marginal binding to known canonical PRC1 targets (underlined). (
E) Comparison of CpG island (CGI) length (left) and 5-methyl-cytosine (5mC) levels (right) of CBX7-, RING1B-, and/or PCGF6-bound genes. The number of genes included in each subset is shown at the bottom. (
F) A heat map view of RING1B distribution in ±4 kb genomic regions around TSS in wild type (WT), and
Kdm2b-KO ESCs. RING1B-bound genes are further subclassified by binding of PCGF6 and CBX7 (left). Average distribution and p-value for its change in
Kdm2b-KO are also shown (right). (
G) Gene expression changes in
Kdm2b-KO ESCs. Box plot representation of gene expression changes induced by deletion of
Kdm2b for genes bound by CBX7, PCGF6 and/or RING1B. The box plots represent the median (horizontal line), interquartile range (box), range (whiskers), and outliers (circles). The number of genes included in each subset is shown at the bottom. The
p-values for the difference of expression changes between the indicated two groups were determined by the Student’s
t-test and are indicated above each graph.